CIK 0001739410 · <br>Emerging growth company
Rallybio Corp
Sign in to watch- Ticker
- RLYB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851083789
- Phone
- 203- 859-3820
- Business address
- 234 CHURCH STREET, SUITE 1020, NEW HAVEN, CT, 06510
- Former names
- Rallybio Holdings, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $9,608
- in 1 filing
Net −$9,608. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-08 | PARMAR KUSH Director | Sale | −139,539 | $13.05 | $1.8M | 2,645,087 |
| 2022-02-08 | PARMAR KUSH Director | Sale | −70,461 | $13.05 | $920K | 1,335,637 |
| 2022-02-07 | Fryer Jeffrey M Chief Financial Officer | Grant or award · Option (Right to Buy) | +62,000 | 62,000 | ||
| 2022-02-07 | Uden Stephen See Remarks | Grant or award · Option (Right to Buy) | +62,000 | 62,000 | ||
| 2022-02-07 | MACKAY MARTIN Chief Executive Officer | Grant or award · Option (Right to Buy) | +62,000 | 62,000 | ||
| 2022-02-07 | Ryder Steven Chief Medical Officer | Grant or award · Option (Right to Buy) | +62,000 | 62,000 | ||
| 2022-01-19 | Fryer Jeffrey M See Remarks | Purchase | +1,400 | $8.70 | $12K | 44,048 |
| 2022-01-13 | Uden Stephen See Remarks | Purchase | +4,193 | $9.06 | $38K | 718,320 |
| 2022-01-13 | Uden Stephen See Remarks | Purchase | +807 | $9.62 | $8K | 719,127 |
| 2022-01-12 | Uden Stephen See Remarks | Purchase | +5,000 | $10.55 | $53K | 714,127 |
| 2022-01-11 | MACKAY MARTIN Chief Executive Officer | Purchase | +4,496 | $10.65 | $48K | 282,609 |
| 2022-01-10 | MACKAY MARTIN Chief Executive Officer | Purchase | +5,504 | $10.10 | $56K | 278,113 |
| 2022-01-07 | Fryer Jeffrey M See Remarks | Purchase | +705 | $8.97 | $6K | 33,353 |
| 2022-01-07 | Fryer Jeffrey M See Remarks | Purchase | +9,295 | $9.44 | $88K | 42,648 |
| 2022-01-03 | Hopfner Robert Lorne Director | Grant or award · Option (Right to Buy) | +6,242 | 6,242 | ||
| 2022-01-03 | HUNT RONALD Director | Grant or award · Option (Right to Buy) | +6,242 | 6,242 | ||
| 2022-01-03 | PARMAR KUSH Director | Grant or award · Option (Right to Buy) | +5,772 | 5,772 | ||
| 2022-01-03 | SHANNON TIMOTHY M Director | Grant or award · Option (Right to Buy) | +6,041 | 6,041 | ||
| 2022-01-03 | Soteropoulos Paula Director | Grant or award · Option (Right to Buy) | +5,369 | 5,369 | ||
| 2021-08-02 | PARMAR KUSH Director | Purchase | +615,384 | $13.00 | $8.0M | 1,406,098 |
Page 8 of 11 · 216 trades